Audit requirements and expectations, The good and better about MDSAP Regulations
Abstract
The most sure-fire way to pass MDSAP audit with flying colours is to have an effective Quality Management System (QMS). Having a good QMS will make sure work is correctly documented, kept up to date, and easy to present to an auditor. For regulators too, it means a reduced burden. There is pooling of regulatory resources. The audits are conducted by Auditing Organizations designated by the regulatory bodies. The MDSAP program is expected to improve audit predictability because a standardized audit model has been introduced. Every audit follows the same set of steps. For the first time, a grading system is introduced for noncompliance. This approach helps reduce subjectivity. MDSAP has a very rigid auditing process to ensure the proper market authorizations have been obtained and facility registrations have occurred but not represent Marketing Authorization. Recently proposed greater alignment of FDA Quality System Regulation (QSR) with ISO 13485, would bring US QMS requirements for medical device manufacturers closer in line with quality system requirements in markets such as the European Union, Japan and Australia, potentially streamlining medical device registration and compliance processes across the US and other markets.
Downloads
References
https://fda.report/media/147457/MDSAP-AU+P0002.006+MDSAP-Audit-Approach.pdf
2. Emergobyul. US FDA formally proposes aligning Quality System Regulations with ISO 13485 [Internet]. US FDA; 2018 May 18 [cited 2022 Feb 03]. Available from:
https://www.emergobyul.com/blog/2022/02/us-fda-formally-proposes-aligning-quality-system-regulations-iso-13485
3. Orielstat. The Medical Device Single Audit Program: How to Prepare for (and Maintain) MDSAP Certification [Internet]. Orielstat; 2019 Feb 22 [cited 2019 Feb 02]. Available from:
https://www.orielstat.com/blog/medical-device-single-audit-program/
4. James G. Rimsys [Internet]. MDSAP device marketing authorization and facility registration; [cited 2020 Sep 09]. Available from: https://www.rimsys.io/blog/mdsap-device-marketing-authorization
5. Medical Device Single Audit Program (MDSAP) [Internet]. US FDA; 2022 Feb 07 [cited 2022 Feb 07]. Available from:
https://www.fda.gov/medical-devices/cdrh-international-programs/medical-device-single-audit-program-mdsap
6. ISO 13485:2016 Medical Devices-Quality Management Systems-Requirements for regulatory purposes, Clause 2; 2016 Mar.
7. Quality System Regulation (21 CFR Part 820) 4–1–12 Edition. Specific requirements of medical device regulatory authorities participating in the MDSAP program.
8. EU MDR 2017/745, MDD 93/42/EEC [Internet]. ec.europa.eu; 2021 May 25 [cited 2022 Feb 07]. Available from:
https://ec.europa.eu/growth/single-market/european-standards/harmonised-standards/medical-devices_en
9. ISO 9001:2015 Quality Management Systems – Requirements [Internet]. ISO.org; 2015 Sep [cited 2022 Feb 07]. Available from:
https://www.iso.org/standard/62085.html
10. Quality Management System requirements of the Conformity Assessment Procedures of the Australian Therapeutic Goods (Medical Devices) Regulations (TG(MD)R Sch3) 2002; 2021 May 5
11. Brazilian Good Manufacturing Practices (RDC ANVISA 16/2013; 2013Apr 01.
12. Health Canada, Medical Device Regulations, SOR/98-282; 2021 Mar 31.
13. Japan Ordinance on Standards for Manufacturing Control and Quality Control of Medical Devices and In Vitro Diagnostic Reagents (MHLW Ministerial Ordinance No. 169); 2005 Sep 05.
14. Celegence AJ. MDSAP Audit Guide [Internet]. 2019 Aug 01 [cited 2022 Feb 02]. Available from:
https://www.celegence.com/mdsap-audit/
15. Sierra labs. Medical Device Single Audit Program (MDSAP) Explained [Internet]. 2019 Aug 01 01 [cited 2022 Feb 02]. Available from:
https://blog.sierralabs.com/medical-device-single-audit-program-mdsap-explained
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM
